Get startedLog in
    Picture of Wai Chun Bio Technology logo

    660 — Wai Chun Bio Technology Income Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    Basic MaterialsHighly SpeculativeMicro CapValue Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Wai Chun Bio Technology, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2022
    June 30th
    2023
    June 30th
    2024
    June 30th
    Period Length:12 M12 M18 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue5795681,007774370
    Cost of Revenue
    Gross Profit4948.990.250.434.2
    Selling / General / Administrative Expenses
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses564558982762430
    Operating Profit15.19.5324.711.4-60.3
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes9.061.613.78-5.7-78.2
    Provision for Income Taxes
    Net Income After Taxes8.990.995-1.39-10.1-65.7
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-3.16-8.15-21.5-15.4-44.2
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-3.16-8.15-21.5-15.4-44.2
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.019-0.05-0.096-0.091-0.037
    Dividends per Share
    Special Dividends per Share